Search results
Showing results for
UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.
CDIN1-Codanin-1 complex defective in congenital dyserythropoietic anaemia type I is an RNA nuclease.
Conference paper
Brolih S. et al, (2026), Nat Commun
Tirapazamine sensitises hypoxic homologous recombination-proficient NSCLC to PARP inhibition.
Journal article
Jiang Y. et al, (2026), Cell Death Discov
Addition of rituximab to first-line treatment of Burkitt lymphoma in children and young adults in Tanzania: a cost-utility analysis
Journal article
MORRELL L. et al, (2026), Journal of Clinical Oncology Global Oncology
Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY Study.
Journal article
Jackson A. et al, (2026), Lancet Reg Health Eur, 66
Current status of radionuclide therapy targeting PARP in cancer: challenges and prospects.
Journal article
Kurniawan A. et al, (2026), Eur J Nucl Med Mol Imaging
CT radiomics for survival risk stratification in resectable colorectal liver metastases: a multi-centre study.
Journal article
Mian A. et al, (2026), Sci Rep, 16
A multi-center clinical evaluation on first-in-class ROP-based IGRA for tuberculosis diagnosis.
Journal article
Li Q. et al, (2026), iScience, 29
Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.
Journal article
Puhr HC. et al, (2026), Eur J Cancer, 241
Supplementary Table 4 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Table 2 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 4 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 5 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Figure 4 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Table 8 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 7 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Table 3 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Data 1 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)
Supplementary Figure 5 from Coevolution of Atypical BRAF and KRAS Mutations in Colorectal Tumorigenesis
Other
Woolley CE. et al, (2026)